Gaithersburg biotech Emergent BioSolutions is acquiring French pharmaceutical giant Sanofi’s smallpox vaccine business in an all-cash deal worth up to $125 million. The company will pay $97.5 million up front to Sanofi and an additional $27.5 in near-term regulatory and manufacturing milestone payments in the deal. Emergent — — which has a manufacturing facility in East Baltimore — will add the only smallpox vaccine licensed by the Food and Drug Administration to its existing portfolio of…
from http://www.bizjournals.com/baltimore/news/2017/07/14/emergent-bioslutions-acquires-sanofi-smallpox.html?ana=RSS%26s=article_search
via http://baltimorecheckbook.tumblr.com/post/162985759492
No comments:
Post a Comment